Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 5
2008 3
2009 1
2010 2
2011 2
2012 3
2013 1
2014 2
2015 4
2016 5
2017 9
2018 5
2019 5
2020 2
2021 6
2022 13
2023 6
2024 18
2025 18
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023.
Latzka J, Assaf C, Bagot M, Cozzio A, Dummer R, Guenova E, Gniadecki R, Hodak E, Jonak C, Klemke CD, Knobler R, Morrris S, Nicolay JP, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Quaglino P, Ranki A, Scarisbrick J, Stadler R, Väkevä L, Vermeer MH, Wehkamp U, Whittaker S, Willemze R, Trautinger F. Latzka J, et al. Among authors: nicolay jp. Eur J Cancer. 2023 Dec;195:113343. doi: 10.1016/j.ejca.2023.113343. Epub 2023 Sep 18. Eur J Cancer. 2023. PMID: 37890355 Free article. Review.
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.
Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators. Kim YH, et al. Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Lancet Oncol. 2018. PMID: 30100375 Free article. Clinical Trial.
Radiotherapy in cutaneous lymphomas: Recommendations from the EORTC cutaneous lymphoma tumour group.
Elsayad K, Guenova E, Assaf C, Nicolay JP, Trautinger F, Stadler R, Waldstein C, Boterberg T, Meijnders P, Kirova Y, Dobos G, Duque-Santana V, Riggenbach E, Elsheshtawy W, Niezink A, Papadavid E, Scarisbrick J, Vermeer M, Neelis KJ, Bagot M, Battistella M, Quaglino P, Knobler R, Kempf W, Maklad A, Adeberg S, Kouloulias V, Simontacchi G, Corradini S, König L, Eich HT, Cowan R, Correia D. Elsayad K, et al. Among authors: nicolay jp. Eur J Cancer. 2024 Nov;212:115064. doi: 10.1016/j.ejca.2024.115064. Epub 2024 Oct 8. Eur J Cancer. 2024. PMID: 39418694 Free article. Review.
Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa-Induced Dyskinesia.
Sosero YL, Bandres-Ciga S, Ferwerda B, Tocino MTP, Belloso DR, Gómez-Garre P, Faouzi J, Taba P, Pavelka L, Marques TM, Gomes CPC, Kolodkin A, May P, Milanowski LM, Wszolek ZK, Uitti RJ, Heutink P, van Hilten JJ, Simon DK, Eberly S, Alvarez I, Krohn L, Yu E, Freeman K, Rudakou U, Ruskey JA, Asayesh F, Menéndez-Gonzàlez M, Pastor P, Ross OA, Krüger R; NCER‐PD Consortium; Corvol JC, Koks S, Mir P, De Bie RMA, Iwaki H, Gan-Or Z; International Parkinson's Disease Genomic Consortium. Sosero YL, et al. Mov Disord. 2024 Oct;39(10):1773-1783. doi: 10.1002/mds.29960. Epub 2024 Aug 12. Mov Disord. 2024. PMID: 39132902 Free PMC article.
Estrogen receptor β stimulation as a possible novel therapeutic target for cutaneous T-cell lymphoma.
Özistanbullu D, Wilhelm R, Reichenbach G, Doll M, Bahrami K, Zöller N, Schnütgen F, König A, Scheller T, Winkler L, Spahn P, Jäger M, Nicolay JP, Pfeilschifter J, Schilling B, Kaufmann R, Koch A, Kippenberger S, Kleemann J, Meissner M. Özistanbullu D, et al. Among authors: nicolay jp. Blood Adv. 2025 Jun 10;9(11):2651-2662. doi: 10.1182/bloodadvances.2024015132. Blood Adv. 2025. PMID: 40020159 Free PMC article.
Pegylated interferon-α2a in cutaneous T-cell lymphoma - a multicenter retrospective data analysis with 70 patients.
Hansen-Abeck I, Geidel G, Abeck F, Kött J, Cankaya R, Dobos G, Mitteldorf C, Nicolay JP, Albrecht JD, Menzer C, Livingstone E, Mengoni M, Braun AD, Wobser M, Klemke CD, Tratzmiller S, Assaf C, Terheyden P, Klespe KC, Schneider SW, Booken N. Hansen-Abeck I, et al. Among authors: nicolay jp. J Dtsch Dermatol Ges. 2024 Nov;22(11):1489-1497. doi: 10.1111/ddg.15511. Epub 2024 Oct 2. J Dtsch Dermatol Ges. 2024. PMID: 39358932
Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas.
Costanza M, Giordano C, von Brünneck AC, Zhao J, Makky A, Vinh K, Montes-Mojarro IA, Reisinger F, Forchhammer S, Witalisz-Siepracka A, Edtmayer S, Stoiber D, Yin G, Horst D, Fischer A, Siebert R, Nicolay JP, Yin M, Janz M, Fend F, Becker JC, Schürch CM, Kenner L, Assaf C, Merkel O, Mathas S. Costanza M, et al. Among authors: nicolay jp. Br J Dermatol. 2025 Apr 28;192(5):883-895. doi: 10.1093/bjd/ljaf001. Br J Dermatol. 2025. PMID: 40036608
103 results